Emergent BioSolutions

-$1.45 (-2.69%) Today
+$0.01 (+0.02%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EBS and other ETFs, options, and stocks.

About EBS

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats.

CEO
Robert G. Kramer
Employees
2,200
Headquarters
Gaithersburg, Maryland
Founded
1998

EBS Key Statistics

Market Cap
2.81B
Price-Earnings Ratio
9.50
Dividend Yield
—
Average Volume
455.13K
High Today
$53.75
Low Today
$52.37
Open Price
$53.18
Volume
365.18K
52 Week High
$127.20
52 Week Low
$52.36

EBS News

Simply Wall St17h

Emergent BioSolutions Inc.'s) market cap declines to US$2.8b but insiders who sold US$754k stock were able to hedge their losses

Insiders at Emergent BioSolutions Inc. ( ) sold US$754k worth of stock at an average price of US$92.37 a share over the past year, making the most of their inve
Simply Wall StSep 23

Emergent BioSolutions Inc. Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

It is hard to get excited after looking at Emergent BioSolutions' (NYSE:EBS) recent performance, when its stock has declined 15% over the past month. But if you

EBS Earnings

$0.00
$1.22
$2.45
$3.67
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure